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The identification and chromatographic characterization of the leukotoxin of Pasteurella haemolytica is
described. The toxin, which has an apparent native molecular weight of greater than 400,000 as judged by gel
exclusion chromatography, has a 105-kilodalton (105K) polypeptide as its major protein component. The
proteolytic degradation of the 105K polypeptide could be correlated with the loss of toxin activity in aging
cultures of P. haemolytica. Antisera raised against purified 105K polypeptide neutralized toxin activity. A
3.9-kilobase-pair fragment of the P. haemolytica genome cloned into a plasmid vector resulted in the production
of intracellular toxin in Escherichia coli host cells. The restriction map of this clone shows significant overlap
with the map of a previously reported leukotoxin clone (R. Y. C. Lo, P. E. Shewen, C. A. Strathdee, and C.
N. Greer, Infect. Immun. 50:667-671, 1985). Finally, antisera raised against the 105K species labeled the P.
haemolytica cell surface in a nonuniform, punctate manner.
Pasteurella haemolytica is the pathogenic agent in
pneumonic pasteurellosis, which is a principal factor in the
morbidity and mortality associated with the complex syn-
drome called shipping fever. This organism secretes a toxin
which kills the leukocytes of cattle, goats, and sheep but not
those of nonruminants (5, 12). Since phagocytic cells are
considered to be a major mechanism of host defense against
respiratory infections, the P. haemolytica leukotoxin is
likely to be a major virulence factor.
There have been several reports of the identification of the
P. haemolytica toxin from culture supernatants. Himmel et
al. (10) purified a protein with a native molecular weight of
150,000 as judged by gel filtration and described its dissocia-
tion into 20,000- and 50,000-molecular-weight components in
the presence of sodium dodecyl sulfate (SDS). However,
their most purified preparations killed less than 1% of bovine
alveolar macrophage cells after a 6-h exposure by using
trypan blue exclusion. Baluyut et al. (2) claimed, on the basis
of ultrafiltration, that the leukotoxin has a native molecular
weight greater than 300,000 but did not characterize the
material at the molecular level. Lo et al. (13) reported the
cloning of a P. haemolytica DNA fragment, the expression
of which yielded leukotoxin activity in Escherichia coli cell
lysates. Mosier et al. (17) reported that the native cytotoxin
has a molecular weight of 160,000 as judged by gel filtration
chromatography. This material yielded a number of distinct
polypeptide species when subjected to SDS-polyacrylamide
gel electrophoresis (SDS-PAGE). In this report, we demon-
strate that the toxin has a single polypeptide component,
with an apparent molecular weight of 105,000, as judged by
SDS-PAGE, which has a primary proteolytic breakdown
product with a molecular weight of 95,000 both in P.
haemolytica culture supernatants and within E. coli cells
carrying the cloned toxin gene.
MATERIALS AND METHODS
Bacterial strains, media, and culture conditions. Repre-
sentative P. haemolytica strains from each of the 15
* Corresponding author.
serotypes (7) were obtained courtesy of E. L. Biberstein,
University of California, Davis. Biotype A, serotype 1
strains were obtained from the Texas Veterinary Diagnostic
and Laboratory System in College Station and Amarillo,
Tex. P. haemolytica cultures were grown in brain heart
infusion (BHI; Difco Laboratories), Dulbecco minimal es-
sential medium (DMEM) supplemented with 10% fetal calf
serum (FCS), or a dialysate (DBHI) obtained by dialyzing
10-fold-concentrated BHI against 9 volumes of distilled
water. LB-Amp was Luria broth (16) supplemented with
ampicillin (50 ,ug/ml). Minimal glycerol medium was M9
minimal medium (16) with 0.2% glycerol as a carbon source.
SDS-PAGE and Western blotting. SDS-PAGE was per-
formed as previously described (1). Western blotting (immu-
noblotting) was performed exactly as described by Towbin
et al. (22). Immunoreactive bands were visualized with a
second antibody conjugated to horseradish peroxidase (9).
Leukotoxin assay. The continuous bovine lymphoma cell
line BL-3 obtained from G. Theilen, University of Califor-
nia, Davis, was used to estimate leukotoxin activity. BL-3
cells undergo characteristic morphological changes upon
exposure to active leukotoxin (Fig. 1). In a standard assay,
106 cells were incubated with toxin samples (less than 50 ,ul)
for 1 hour at 37°C in 1 ml of growth medium, which was
Leibovitz L-15 Medium with L-glutamine (Gibco Laborato-
ries) supplemented with 10% FCS. It was observed that
certain lots of FCS were inhibitory to toxin activity. Some
assays were performed in phosphate-buffered saline (8 g of
NaCl, 0.2 g of KCI, 1.15 g of Na2HPO4, 0.2 g of KH2PO4,
and 1 g of glucose per liter, supplemented with 0.5% bovine
serum albumin and 1 mM CaC12). The calcium was found to
be required for leukotoxin activity at low concentrations of
toxin and could not be replaced by magnesium, manganese,
or zinc. One unit of toxin activity is defined as the minimal
amount of toxin, as determined by serial dilution, required to
produce the morphological change in >95% of the input
BL-3 cells. This simple visual assay correlates well with
more tedious assays based on the killing of freshly isolated
bovine macrophages, leukocytes, and neutrophils (2, 4, 18),
as well as with a similar assay based on neutral red uptake of
BL-3 cells described by Greer and Shewen (8).
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FIG. 1. Visual assay of leukotoxin activity by using bovine
lymphoma (BL-3) cells. Cells were incubated in the absence (A) or
presence (B) of leukotoxin as described in Materials and Methods.
Phase-contrast micrograph magnification, x250.
Source of neutralizing antibodies. Antibodies from cattle
experimentally infected with live P. haemolytica were ob-
tained from R. Loan, Department of Veterinary Microbiol-
ogy and Parasitology, College of Veterinary Medicine,
Texas A&M University. Antibodies were also raised in New
Zealand White male rabbits immunized with Formalin-killed
P. haemolytica. In addition, antibodies specific for the
105-kilodalton (105K) polypeptide species secreted by P.
haemolytica were raised in New Zealand White male rabbits
by immunization with material purified by preparative SDS-
PAGE. Gel slices containing the 105-kilodalton band were
directly emulsified with Freund adjuvant and injected sub-
cutaneously into rabbits.
Immunological techniques. Immunoprecipitation of culture
supernatants and French pressates and analysis of SDS-
polyacrylamide gel were done as previously described (15).
Immunoprecipitation of whole-cell extracts were done es-
sentially as described by Stader et al. (20). Briefly, 1 ml of a
saturated culture of cells was centrifuged for 2 min in an
Eppendorf Microfuge (Beckman Instruments, Inc.), and the
pellet was suspended in 50 ,u1 of 1% SDS-1 mM EDTA
(ethylenediaminetetraacetic acid), pH 7.8. This suspension
was boiled for 1 min, supplemented with 0.65 ml of TSET
buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, and
2% Triton X-100), and centrifuged again for 10 min at room
temperature in the microfuge. The insoluble pellet was
removed with a toothpick, and the supernatant was immu-
noprecipitated as described above. Indirect immunofluores-
cent staining of P. haemolytica was performed by using
fresh, logarithmic-phase cells grown in BHI. The cells from
50 ,ul of culture were washed three times in sterile 0.15%
NaCl. After the last wash, the cells were resuspended in 50
,ul of undiluted antiserum and incubated at 37°C for 30 min.
After incubation, the cells were washed three times with
PBS. For staining, the cells were resuspended in buffer
containing fluorescein-conjugated goat anti-rabbit immuno-
globulin G (heavy and light chain specific; Cappel Labora-
tories) and incubated at 37°C for 0.5 h. After the incubation,
the cells were washed with phosphate-buffered saline three
times and were immobilized on an agar-coated microscope
slide. Microscopy was performed with a Leitz Dialux 20
microscope equipped with phase-contrast optics and epi-
illumination for fluorescence.
Preparation of crude leukotoxin. P. haemolytica biotype
A, serotype 1 was grown in DBHI to an A550 of 4, and the
culture supernatant was collected by low-speed centrifuga-
tion. The supernatant was concentrated 10-fold by ultrafil-
tration by using an Amicon DC-2 hollow-fiber apparatus with
a molecular weight cutoff of 30,000. Tris base (20 mM, 2
liters) adjusted to pH 8.0 with HCI was added, and the
mixture was concentrated 20-fold by ultrafiltration. This step
was necessary to achieve the salt and pH requirements of
DEAE ion-exchange chromatography, since dialysis at this
stage resulted in the loss of toxin activity. The concentrated
supernatant was subjected to ultracentrifugation at 117,000
x g for 1 h at 4°C to remove insoluble material. This
preparation contained typically 5,000 U/ml and was used as
the crude toxin preparation in all chromatography experi-
ments.
Cloning of toxin gene. P. haemolytica chromosomal DNA
was prepared by the method of Silhavy et al. (19) and
partially digested with Sau3A. The digest was fractionated
by sedimentation in neutral sucrose (14), and fractions
containing 3- to 10-kilobase-pair fragments, as judged by
agarose gel electrophoresis, were pooled and concentrated
by alcohol precipitation to a final level of 100 p.gIml. The
omega-complementing plasmid pHG165 was chosen as the
library vector. Plasmid vector pHG165 (10 ,ug) (21) was
cleaved with BamHI and treated with alkaline phosphatase
to remove terminal phosphates. After phenol extraction and
concentration by ethanol precipitation, the vector DNA was
mixed with the 3- to 10-kilobase-pair P. haemolytica DNA at
TABLE 1. Neutralization of leukotoxin activitya
Neutralization at antibody dilution:
Antiserum source
1 1:2 1:4 1:8 1:16 1:32 1:64
Cow -+- +
Rabbit - - - - ± + +
Rabbit (preimmune) + ND ND ND ND ND ND
a A 1-pIU sample of partially purified toxin (100 U) was mixed with 10-,ul of
serially diluted antiserum obtained from experimentally infected cattle or from
a rabbit immunized with the 105K polypeptide which had been purified by
preparative SDS-PAGE. After a 1-h incubation at 37°C, 106 BL-3 cells in 1 ml
of L-15 growth medium was added to each mixture and toxin activity was
assessed as described in Materials and Methods. +, >95% of the BL-3 cells
showed morphological changes induced by leukotoxin; -, complete neutral-
ization of leukotoxin; ND, not done.
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FIG. 2. Immunoprecipitation of culture supernatants from different P. haemolytica serotypes. P. haemolytica cultures were grown in BHI
medium supplemented with 10% FCS. Late logarithmic-phase supernatant (300 ,ul) was immunoprecipitated with 10 ,ul of bovine antiserum
and analyzed on a polyacrylamide gel with silver staining as described in Materials and Methods. Molecular size is given in kilodaltons. Lanes:
1 and 25, molecular weight standards; 2, control immunoprecipitation by using 300 ,ul of growth medium; 3 to 17, P. haemolytica serotypes
1 to 15; 18 to 24, different clinical field isolates of P. haemolytica biotype A, serotype 1. The major diffuse band at approximately 50
kilodaltons is the immunoglobulin G heavy chain added in the immunoprecipitation.
a molar ratio of 1:5 and treated with T4 DNA ligase for 16 h
at 18°C. The ligation mixture was transformed into alpha-
complementing E. coli TB1 hsdR (11), and transformants
were selected on LB-Amp with 100 ,ug of X-Gal (5-bromo-
4-chloro-3-indolyl-p-D-galactopyranoside) per ml. Transform-
ants were obtained at approximately 1,000 colonies per pg of
input DNA, approximately 80% of which were colorless and
thus contained insert DNA. Immunodetection of the produc-
tion of the P. haemolytica leukotoxin was done by the
method of Hawkes et al. (9) with antisera from rabbits
immunized with gel-purified 105K antigen (see below) and
from cattle experimentally infected with P. haemolytica.
Positive clones were cultured in LB-Amp and checked for
the production of the 105K antigen by Western blotting and
immunoprecipitation. To test for toxin activity in the clones,
25-ml cultures grown in LB-Amp were concentrated fivefold
in growth medium by centrifugation and lysed by a single
passage through a French press at 16,000 lb/in2. The lysate
was cleared of unlysed cells by centrifugation at 3,000 x g
for 5 min and used in serial dilutions in the BL-3 assay (see
above).
RESULTS
105K polypeptide toxin component. The supernatant fluids
of P. haemolytica biotype A, serotype 1 cultures grown in
either of two commonly used growth media, BHI or DMEM-
FCS, had comparable levels of leukotoxin activity (200 U/ml
for DMEM and for 400 U/ml for BHI) as judged by the BL-3
cytotoxicity assay. This toxin activity was inactivated by
antiserum obtained from cattle infected with live P.
haemolytica cells (Table 1). Immunoprecipitation with this
antiserum of the culture supernatants from a number of
clinical isolates of P. haemolytica biotype A, serotype 1,
which is most commonly associated with pneumonic
pasteurellosis, and from other serotypes revealed a number
of major bands (Fig. 2). The major common feature was the
105K species, which we provisionally identified as a compo-
nent of the toxin.
On the basis of the band intensity in analyses such as the
one shown in Fig. 2, we estimate that approximately 0.5 ,ug
of 105K protein per ml was present in supernatants from
cultures in late logarithmic phase. Initial attempts to purify
the toxin from BHI and DMEM-FCS failed, because these
media contain gram quantities of nondialyzable, ammonium-
sulfate-precipitable material. Instead, it was found that
DBHI can serve as an acceptable growth medium, typically
yielding 1,000 U of toxin activity per ml in the late log phase
(Fig. 3A). Overnight aeration of the saturated culture re-
sulted in the loss of the toxin activity, as reported previously
(2). Immunoprecipitation with the bovine antibody shows
that the kinetics of the accumulation of the 105K species
paralleled the time course of toxin production (Fig. 3B).
Accompanying the loss of toxin activity during the overnight
aeration was the degradation of the 105K species into
lower-molecular-weight immunoreactive forms (Fig. 3B,
lane 10). Proteolytic degradation of the 105K species was
also seen in BHI and DMEM-FCS, with the principal
degraded form a 95K species (data not shown).
Toxin neutralization by anti-105K antibodies. Antibodies
were raised in rabbits against the 105K polypeptide purified
by preparative SDS-PAGE. These antibodies neutralized
toxin activity (Table 1) and showed a single precipitin line in
Ouchterlony immunodiffusion gels (data not shown). West-
ern blots using this antiserum demonstrated not only that a
single supernatant band was labeled, but also that the cell
pellet contained another immunoreactive species at 95 kilo-
daltons (Fig. 4).
Chromatographic behavior of toxin. Supernatant from a
late log-phase culture was subjected to several kinds of
chromatographic analysis. Toxin activity eluted from
DEAE-cellulose at 0.3 to 0.4 M NaCl (Fig. 5A), and SDS-
PAGE analysis of the column fractions revealed that the
105K species was also eluted in the same fractions (Fig. SB).
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FIG. 4. Western blot analysis by using the anti-105K antibody.
The rabbit antiserum prepared against the gel-purified 105K species
was used at a 1:200 dilution. Lanes: 1, DBHI control; 2, cellular
proteins; 3, culture supernatant.
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FIG. 3. Kinetics of leukotoxin production and the appearance of
the 105K species during culture growth. P. haemolytica cells were
grown in DBHI, and samples were removed at various times. The
samples were assayed for leukotoxin activity and for the presence of
the 105K polypeptide as described in Materials and Methods. (A)
Kinetics of culture growth and leukotoxin production. (B) Kinetics
of 105K polypeptide synthesis. Lanes: 1, molecular weight stan-
dards; 2 to 11, immunoprecipitation by using 10 ,ul of the bovine
antiserum and 300 RlI of DBHI (lane 2) or 300 ,ul of culture
supernatant from samples taken from a culture at 180 min (lane 3),
210 min (lane 4), 240 min (lane 5), 270 min (lane 6), 300 min (lane 8),
330 min (lane 9), 360 min (lane 10), and 24 h (lane 11).
Neither toxin activity nor the 105K species was bound to
carboxymethyl-cellulose at pH 6.5 or to octyl-Sepharose at
pH 8.0 in 1 M (NH4)2S04 (data not shown). In addition, the
105K polypeptide and toxin activity showed apparent mo-
lecular weights greater than 400,000 based on gel filtration
chromatography (Fig. 6).
Identification of cloned toxin gene product. Plasmid librar-
ies of P. haemolytica genomic DNA were screened with the
bovine and rabbit antisera, and one clone, containing the
plasmid pYFC19 with a 3.9-kilobase-pair insert, was shown
to react with both antisera and to produce intracellular toxin
activity (approximately 50 U/mI of overnight culture [data
not shown]). A 105K polypeptide could be immunopre-
cipitated from lysates of the clone. In addition, lower-mo-
lecular-weight species, especially a 95K polypeptide, were
immunoprecipitated at various proportions of the 105K
polypeptide, depending on the manner of cell disruption
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FIG. 5. Elution of leukotoxin activity and the 105K species from
DEAE-cellulose. Crude leukotoxin prepared as described in Mate-
rials and Methods was applied to a DEAE-cellulose column (1 by 8
cm) in 20 mM Tris, pH 8.0. Elution was accomplished with a linear
salt gradient (O to 0.7 M NaCl). (A) Each fraction (6 ml) was assayed
for toxin activity by serial dilution. Approximately 70o of the
applied toxin activity was recovered. (B) Samples from selected
fractions were analyzed by SDS-PAGE. Lanes 1 and 12 contain
molecular weight standards. Lanes 2 to 11 contain fractions 11 to 20,
respectively.
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FIG. 6. Gel permeation chromatography of the leukotoxin.
Crude leukotoxin prepared as described in Materials and Methods
was applied to a Sephacryl S-300 column (2.5 by 45 cm) and eluted
with 20 mM Tris, pH 8.0. Each fraction (2.5 ml) was assayed for
leukotoxin activity by serial dilution. Approximately 60% of the
applied leukotoxin activity was recovered. Fractions 41 to 110
contained less than 50 U of leukotoxin activity per ml. OD280,
Optical density at 280 nm; V, void volume; ,8-gal, (3-galactosidase;
BSA, bovine serum albumin.
(Fig. 7). Restriction analysis of the insert showed that the
cloned fragment had significant overlap with the 6.3-kilobase
fragment reported by Lo et al. (13) to encode toxin activity
(Fig. 8).
Localization of cross-reacting material to the cell surface.
Since the anti-105K antibody reacted with a 95K species in
the cell pellet (Fig. 4), the cell surface was examined for
evidence of cross-reacting material by indirect immunofluo-
rescence. While the antibody against Formalin-fixed cells
labeled the surface of P. haemolytica uniformly, the anti-
105K antibody gave a nonuniform or punctate labeling
pattern (Fig. 9). This punctate distribution was not repro-
duced by using the preimmune serum and was not affected
by labeling at low temperature or with a monovalent Fab
fraction (data not shown).
DISCUSSION
We identified a 105K polypeptide as the sole polypeptide
component of the leukotoxin produced by P. haemolytica.
This molecular species was preliminarily identified as a
candidate for the toxin based on the observation that the
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FIG. 7. Immunoprecipitation of cloned leukotoxin produced in
E. coli. Inimunoprecipitations were done with 10 ,u1 of the bovine
antiserum and 300 p.l of P. haemolytica culture supernatant (lane 1),
20 ,ul of French-pressed cell lysates from cultures grown in LB-Amp
(lanes 2 and 3), or whole-cell extracts from cultures grown in
minimal glycerol medium (lanes 4 and 5) prepared as described in
Materials and Methods. Lanes: 2 and 4, E. coli TBlpHG165; 3 and
5, E. coli TBlpYFC19. Molecular sizes are shown in kilodaltons.
A
,.C PV HU
3.9kbp ' 1 3.9kbp
FIG. 8. Comparison of restriction maps of P. haemolytica DNA
inserts in pYFC19 and pPH5. The map of pPH5 is from Lo et al.
(13). The discrepancy between the placement of the PvuI site in the
two maps is unexplained. Abbreviations: A, AvaI; C, ClaI; H,
HindIll; P, PstI; U, PvuI; V, PvuII; kbp, kilobase pairs.
kinetics of its appearance and disappearance from the super-
natants of P. haemolytica cultures paralleled those of the
cytotoxin activity. In addition, secretion of the 105K species
was a common feature of all pathogenic serotypes. Antibod-
ies raised against the 105K polypeptide were shown to
neutralize toxin activity. Previous reports have indicated
that the cytotoxin is a heat-labile protein of a molecular
weight of 150,000 or greater as judged by gel filtration (10)
and ultrafiltration (2). These results can be reconciled with
our present findings by assuming that the active toxin is a
multimer of the 105K protein identified on denaturing gels.
In fact, our preliminary attempts to purify the toxin by gel
filtration suggest that its molecular weight is much greater
than 400,000 (Fig. 6). More difficult to reconcile is the claim
that the cytotoxin is composed of 20K and 50K subunits (10).
This apparent contradiction might be due to the fact that
cytotoxin activity is unstable (Fig. 1) and that the 105K
protein we identified as the toxin is subject to proteolytic
degradation. Previous reports have indicated that there is an
extracellular protease released by P. haemolytica and also
that the cells autolyse in stationary phase (6), potentially
releasing intracellular proteolytic activities. In fact, the
studies purporting to demonstrate the existence of 20K and
50K subunits were performed by using preparations derived
from culture supernatants having variable amounts of low-
molecular-weight material which was antigenically similar to
the high-molecular-weight (150K) form of the toxin (10). In
our hands, the primary breakdown product in culture super-
natants was a 95K polypeptide (Fig. 3B), although subse-
quent degradation to lower-molecular-weight immunoreac-
tive forms has also been seen (data not shown).
Our data support the idea that the 105K species is the only
protein component of the active toxin. The size of the cloned
P. haemolytica DNA fragment which encodes the toxin
protein is only about 0.9 kilobase pairs larger than the
minimum required for a polypeptide of this size. Neverthe-
less, the toxin synthesized in E. coli was apparently full
length and fully active, indicating that no modification spe-
cific to P. haemolytica was required. In addition, the most
highly purified fractions from ion-exchange chromatography
show only the 105K species and the 95K breakdown product
(Fig. SB).
When whole-cell extracts of P. haemolytica were sub-
jected to Western blot analysis by using the 105K-specific
antibody, a 95K band was labeled in addition to the 105K
species. It is not clear what relationship this species has to
the active secreted toxin. At least one of these two forms is
located at the cell surface, as judged by indirect immunoflu-
orescence, and is distributed in a nonuniform, punctate
pattern. It is possible this punctate distribution reflects
structural features of the P. haemolytica envelope which are
involved in the secretion of the extracellular toxin and may
be similar to the zones of adhesion reported by Bayer (3).
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